At its meeting on Wednesday, November 21, 2012, the Public Health Council approved amendments to 105 CMR 970.000, Pharmaceutical and Medical Device Manufacturer Conduct. The final version of the regulation as approved is the document titled “105 CMR 970 Final.” The amendments will be filed with the Secretary of the Commonwealth and should take effect upon publication in the Massachusetts Register on December 7, 2012.
The Department expects to issue guidance on reporting requirements shortly.
Emergency amendments were approved by the Public Health Council and filed with the Secretary of the Commonwealth on September 19, 2012. The effective date of the emergency amendments is September 19, 2012.
-
Notice of Public Hearing
-
Regulations
- Public Testimony
- As of 10/26/12
-
Advanced Medical Technology Association
-
Coalition for Healthcare Communication
-
David Tian
-
Edison Wong, MD
-
Greater Boston chamber of Commerce
-
Health Care for All #2
-
Medical Imaging & Technology Alliance
-
Novartis
-
Organogenesis
file size 1MB
-
Otsuka America Pharmaceutical
-
Pfizer Inc
-
Reshma Ramachandran
-
The Alliance for Patient Access
-
Advanced Medical Technology Association
- As of 10/25/12
- As of 10/24/12
- As of 10/23/12
- As of 10/18/12
- As of 10/17/12
- As of 10/16/12
-
Aimee Sands
-
Cate Solomon, PhD
-
Cathy Romeo
-
David Taylor
-
Deborah Katz
-
Deborah Shields, JD, MPH
-
Elissa Ladd, PhD
-
Elizabeth Schwartz
-
Gloria Villari
-
Janet Blackman
-
Jean Batty
-
Jennifer Haimson
-
Karen Clark
-
Kyle Kahveci
-
Linda Velde
-
Marco Cornelio, MD
-
Mitchell Clionsky, PhD
-
Naomi Myrvaagnes
-
Nina Rossi
-
Sharon Wachsler
-
Valerie Spain
-
Aimee Sands
- As of 10/15/12
- As of 10/10/12
- As of 10/26/12
- Public Testimony
- As of 10/2/12
